Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Choosing the right model for your patient: An introduction to InsightRX Gemini
Resources
Thought Leadership
Sep 10, 2024
Streamlining Patient Care with EHR Integration
Thought Leadership
Jun 28, 2024
AUC Monitoring for Vancomycin: Comparing Estimation Methods
White Papers
Jun 21, 2024
InsightRX White Paper: Implementation Best Practices
Thought Leadership
Jun 13, 2024
Recognizing the value of therapeutic drug monitoring for beta-lactam antibiotics
White Papers
May 29, 2024
Case Study: Pre-/Post-Implementation; Can Bayesian MIPD enhance target attainment and clinical outcomes for patients receiving vancomycin?
Product Innovation
May 28, 2024
Introducing Apollo Gold: Enhancing Data-Driven Insights and Real-Time Recommendations
Scientific Publications
May 21, 2024
Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With Obesity
Scientific Publications
Mar 26, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Scientific Publications
Mar 24, 2024
Maximum a posteriori Bayesian methods out-perform non-compartmental analysis for busulfan precision dosing
1
2
3
4
5
